001 LN Feb 2020

Real-world data provides the opportunity to enhance regulatory decisions for new drugs

Real-world data and evidence provide valuable performance data on a post-approval drug to create a comprehensive clinical snapshot This can later support regulatory and reimbursement decisions and clinical guidelines More and more stakeholders in the pharmaceutical pipeline are recognising the value of real-world data Click here to learn more About SVMPharma SVMPharma is an innovative strategic consultancy, […]

Read More
001 VN Feb 2020

Cancer Electronic Prescribing Records – Real-world Data

  Electronic prescribing records, or EPRs, are a rich untapped source of real-world evidence SVMPharma’s unique EPR real-world studies are one step ahead of the Systemic Anti-Cancer Therapy (SACT) data set Click here to learn more About SVMPharma SVMPharma is an innovative strategic consultancy, specialising in Real World Evidence (RWE) for the pharmaceutical industry. SVMPharma […]

Read More